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Herpes simplex virus 1 (HSV-1) is a widespread global pathogen, of which the strain KOS is one 
of the most extensively studied. Previous sequence studies revealed that KOS does not cluster 
with other strains of North American geographic origin, but instead clustered with Asian strains. 
We sequenced a historical isolate of the original KOS strain, called KOS63, along with a 
separately isolated strain attributed to the same source individual, termed KOS79. Genomic 
analyses revealed that KOS63 closely resembled other recently sequenced isolates of KOS and 
was of Asian origin, but that KOS79 was a genetically unrelated strain that clustered in genetic 
distance analyses with HSV-1 strains of North American/European origin. These data suggest 
that the human source of KOS63 and KOS79 could have been infected with two genetically 
unrelated strains of disparate geographic origins. A PCR RFLP test was developed for rapid 
identification of these strains.  
 





































































Infection with human herpesvirus 1, or herpes simplex virus 1 (HSV-1; genus Simplexvirus, 
subfamily Alphaherpesvirinae, family Herpesviridae, order Herpesvirales) is widespread in 
humans, and is the causative agent of recurrent herpes labialis or genitalis (1). Initial infection 
takes place at epithelial or mucosal surfaces, where virus replicates actively to form self-limited 
lesions that involve interactions with innate and adaptive immunity (1). HSV-1 also enters 
sensory nerve endings and migrates in axons of the peripheral nervous system (PNS) by 
retrograde transport to neuronal nuclei located within sensory or sympathetic ganglia (2–4). It is 
in this cell population that HSV-1 establishes latency. The virus may spontaneously reactivate 
and produce intermittent shedding and/or clinical diseases throughout life (3, 5). Occasional 
invasion of the central nervous system (CNS) by HSV-1 can result in rare but severe and 
sometimes fatal encephalitis (6, 7). While antiviral drugs have been developed for HSV, these 
are only able to target the lytic replication stages and the intermittent cycles of productive viral 
replication (8–11). The latent state is largely refractory to current antivirals (8, 12). HSV remains 
the most studied herpesvirus, and knowledge of HSV has driven key advances in our 
fundamental knowledge of the mechanisms of herpesvirus entry, replication, gene expression, 
assembly and egress (1, 12–14). 
 
The vast majority of laboratory and genetic studies have been restricted to a relatively small 
number of HSV-1 strains and isolates, of which some of the most common are HSV-1 strains F, 
KOS, 17, SC16, and McKrae (1, 15–21). Strains of HSV differ greatly in phenotype, particularly 
in in vivo animal model systems of pathogenesis (18, 22–26). Variants of the same name or 




































































characterizations, demonstrating that this assumption does not always hold true (22, 27). For 
example, strains H166 and H166syn are distinctly different strains, both in phenotype and 
genotype, but arose from the same source patient (28, 29). Two recently published genome 
sequences of HSV-1 McKrae, which were based on strains propagated in different labs, revealed 
coding differences in genes such as UL36 and UL56 (30, 31). We recently demonstrated that 
clonal variants of strains KOS and F could differ in plaque phenotype and harbor numerous 
genetic differences despite their overall clonal identity (29). The genomes of five variants of 
KOS have been published (Table 1) (29, 32–34), and many more variants have been utilized in 
prior studies (15, 22, 34–37), before genome sequencing was a viable option. The history and 
genome sequences of several of these variants have recently been documented by Colgrove et al 
(34). These KOS variants have been noted to differ in virulence in animal models, as well as 
other phenotypes, but the genetic basis of these differences is not yet known (22, 29, 34, 38). 
 
Two variants of HSV-1 KOS, called KOS63 and KOS79, were noted relatively early on to differ 
dramatically in phenotype, both in vitro and in vivo (22). Limited genetic analyses using 
restriction fragment length polymorphisms (RFLP) and single-gene analysis by PCR suggested 
several differences. HSV-1 KOS63, which has an orolabial origin, has been passaged numerous 
times in multiple laboratories (15, 22, 34, 35, 37, 38), and is believed to represent the standard 
KOS isolates that circulate in many laboratories, but this has not been clearly established before 
this work. Another orolabial isolate attributed to the same individual, KOS79, has undergone 
minimal passage in the laboratory (22). In a matched comparison using both peripheral and 
intracerebral routes of HSV-1 infection, Dix et al. found that KOS79 was highly neurovirulent 




































































suggested to be distinct strains on the basis of polypeptide synthesis and RFLP analyses, 
although the primary data were not shown (22). KOS79 has also been shown to harbor an 
extended array of tandem repeats in the neurovirulence protein ICP34.5, relative to a shorter 
array found in a plaque-purified variant of KOS called KOS321 (36, 39). A number of 
differences in the ICP0 promoter region of KOS and KOS79 have also been noted (40).  
 
We set out to address the relatedness of the historical isolate KOS63, and the more virulent strain 
KOS79. We sequenced the full genomes of KOS79 and KOS63 and compared them to five 
published genome sequences of KOS (29, 32–34). We found that KOS63 and previously 
sequenced KOS variants are closely related to one another, akin to clonal variants from a 
parental population (29). However KOS63 and its clonal variants were all genetically distant 
from KOS79 – differing as much as unrelated strains isolated from individuals in disparate 
geographic regions. KOS79 clusters most closely with North American and European strains, 
while KOS63 and its variants cluster with Asian strains. These data provide further evidence that 
individuals may harbor quite disparate viral strains, and will enable future evaluations of the 
genetic basis of the neurovirulence of strain KOS79. 
 
Results 
Full genome sequencing of KOS79 and comparison to KOS 
We used genome-wide comparative sequence analysis to illuminate the genetic relatedness of 
HSV-1 KOS79 to HSV-1 KOS63 and other previously described isolates of the KOS strain 




































































read data from viral nucleocapsid DNA of strains KOS79 and KOS63. Consensus genomes were 
generated for each strain using a previously described combination of de novo assembly and 
reference-guided assembly methods (Table 2; see Methods for details) (29). The genomes of 
KOS79 and KOS63 do not contain any truncated or missing proteins, with the exception of US9 
in KOS63. The presence of a SNP (C>T) in US9, which generates an early stop codon that 
truncates the protein, has been described in multiple prior sequences of the KOS strain (29, 32, 
41). Finding this identical SNP in KOS63 supported the premise that it is indeed closely related 
to the previously sequenced KOS isolates.  
 
To analyze the genetic relatedness of KOS79, KOS63, and the previously sequenced KOS strains 
from our lab and others, we compared the identity and number of variant proteins among these 
strains (Table 3 and Supplementary Table 1). As an out-group, we included for comparison the 
unrelated HSV-1 reference strain 17. We observed that the newly sequenced KOS63 and 
previously sequenced KOS variants shared an average of 99.2% DNA identity (Table 3). In 
contrast, comparison of KOS63 or the other KOS variants to either KOS79 or strain 17 resulted 
in a lower DNA identity of 98.5%. This minor shift in percent identity across the genome 
translated into a sizable number of proteins harboring coding variations in each pairwise 
comparison. Between KOS63 and the KOS variants, an average of just 6 proteins differ in any 
pairwise comparison (Table 3; see Supplementary Table 1 for complete list of variations). This 
is akin to what was previously observed for sister clones from a common parental virus stock 
(29). In contrast, pairwise comparison of any of these vs. KOS79 or strain 17 yields a similarly 
high number of over 60 proteins that harbor coding variations in each pairwise comparison 




































































variants: UL15, UL16, UL20, UL26.5, UL33, VP26 (UL35), UL45, VP22 (UL49A), and UL55, 
several of which were also highly conserved in our prior global analysis of more than 20 
independent HSV-1 strains (42). Overall, the amount of difference observed in these 
comparisons suggested that KOS79 is as different from KOS63-like strains as the unrelated 
strain 17.  
 
Since percent DNA identity does not reflect the location or distribution of differences between 
these genomes, we next estimated the evolutionary distance between these strains. As 
anticipated, the KOS63-like strains had the smallest genetic distance between them in any 
pairwise comparison, correlating with their high DNA identity (Figure 1). Comparison of either 
KOS79 or strain 17 to any of the KOS63-like variants resulted in a larger estimate of genetic 
distance, in keeping with the lower DNA identity (Figure 1). SplitsTree analysis of KOS79, 
KOS63-like variants, and strain 17 confirmed the close relationship among the KOS63-like 
variants, and placed KOS79 and strain 17 at nearly equidistant points away from the KOS63-like 
variants (Supplementary Figure 1). The distance between KOS79 and any of the other KOS 
variants suggests that it is a distinct and unrelated strain.  
 
Genetic distance analysis and the likely geographic origin of strain KOS79 
In a previous comparison of HSV-1 genomes from diverse geographic areas, we found that a 
majority of strains clustered near those from the same geographic origin (42). The KOSDavido 
isolate included in that publication was the sole exception, where despite its USA origin, 
KOSDavido clustered with strains of Asian origin (42, 43). To place KOS79 within the context of 




































































the genetic distance among these strains. In this analysis, KOS79 clustered with 100% bootstrap 
confidence with HSV-1 strains F and H129, which were also isolated in the USA (Figure 2). 
This trio is found within a larger 100% bootstrap confidence cluster, which includes three other 
European and North American strains, HF10, 17 and McKrae. This contrasts with KOS63 and 
KOSDavido, which are assigned to the Asian genetic distance cluster with equal confidence. 
Although attributed to the same individual, KOS63 and KOS79 are fundamentally distinct strains 
that appear to have distant geographic historical origins. 
 
The extensive recombination that is postulated to occur in HSV precludes a cladistic analysis 
using these data on genetic distance (42, 44–48). To investigate the possibility of recombination 
between KOS63 and KOS79 in the original host, we performed SimPlot analysis using KOS79, 
KOS63, a consensus of the European cluster (strains HF10, 17, McKrae, F and H129) and a 
consensus of the Africa-1 cluster (strains E08, E12, E13, E14 and E19) from our prior study 
(Supplementary Figure 2A) (42). We observed that KOS79 is most closely related to the 
European consensus over most of its length, except for a few short regions where it is most 
similar to the Africa-1 consensus (e.g. between kilobases 45-50 and 97-102) or where no 
predominant background can be identified (e.g. between kilobases 60-65 and 80-85). The 
corresponding BootScan plot (Supplementary Figure 2B) shows chi-shaped crossover signals 
supportive of recombination with an African strain at 97-102 kb, although the other two areas of 
African similarity have less well formed signs of crossover. BootScan analysis suggests potential 
recombination between KOS79 and KOS63 at 60-65 kb and 80-85kb, though this finding should 
be viewed with caution because the SimPlot analysis implies genetic equidistance between all 




































































by the deep evolutionary history of the species, the extent of recent intercontinental travel with 
plentiful opportunities for recombination, and the fundamental genetic similarity of all known 
strains (e.g. more than 98.5% identical over any 10 kb window).  
 
Rapid PCR test to distinguish KOS79 and KOS63 
Previous analyses have often grouped KOS63 and KOS79 together (39, 40), although the 
genomic data now indicate that these viruses are likely to be significantly different. Since the 
possibility exists that some labs may have initiated studies with a KOS isolate derived from 
either KOS63 or KOS79, we considered it important to develop an easy assay to distinguish 
these strains. We therefore designed primers to amplify segments of the tegument proteins UL14 
and UL25 (Supplementary Table 2), which each contain a strain-specific restriction digest site 
for NcoI or NdeI (Figure 3). The KOS79 genome contains an NcoI site in UL14 while KOS63 
and its variants do not (Figure 3A). KOS63 and its variants contain an NdeI site in UL25 that is 
not present in KOS79 (Figure 3C). To confirm these sequencing results, nucleocapsid DNA 
from HSV-1 strains 17, KOS63, and KOS79 were used to PCR amplify these regions of UL14 
and UL25. These amplicons were then subjected to restriction digest and analyzed. Examination 
of digestion products revealed the expected patterns (Figure 3B,D). Sanger sequencing was used 
to confirm ten additional SNPs in the UL14 amplicon, and one additional SNP in the UL25 
amplicon, that differ between KOS63 and KOS79 (data not shown). This diagnostic tool can be 
implemented to quickly screen and identify KOS virus stocks or recombinant derivatives within 





































































RFLP analysis of KOS strains  
To validate the newly assembled genomes for KOS63-like and KOS79 using an alternative 
method, actual RFLP patterns were compared to those predicted from each genome sequence. 
Computational comparison of KOS63 and KOS79 predicted the loss of a HindIII restriction site 
in glycoprotein M (gM; UL10) in strain KOS79, resulting in the loss of a 2.8 kb band that exists 
in KOS63-like variants. In the historical lettering system for HSV-1 DNA restriction fragments, 
this 2.8 kb band was referred to as the “O” fragment (49–51) (Figure 4A). As expected, the 2.8 
kb “O” fragment was not present after HindIII digestion of KOS79 DNA, but was present in 
strains KOS and 17 (Figure 4B-C). This O-I fusion event has been previously noted to occur in 
African and European strains of HSV-1, but not in Asian strains (52). Finding the fusion in 
KOS79, but not KOS63, correlates with the geographic history suggested for each strain by 
genetic distance analysis (Figure 2). Taken together, these results indicate the wide genetic 
divergence of KOS79 and KOS63, and highlight that genetic comparisons of these strains will 
reveal many differences regardless of the phenotype under examination (22, 39, 40).  
 
Discussion 
KOS is one of the most extensively used strains in HSV-1 research, particularly in the United 
States. It was isolated from a volunteer in the 1960s (15, 43). In addition to its use in many 
mechanistic and genetic studies, the KOS strain has also been used to develop vaccine antigens 
and vectors (53–56). The full genome sequence of HSV KOS (here called KOSDavido) was first 




































































group, using a 1981 master stock obtained from Neal DeLuca at the University of Pittsburgh 
(JQ780693; here called KOSKinchington) (33), and further detailed by Knipe, Coen and colleagues 
using a master stock provided by Priscilla Schaffer (here called KOSKnipe and KOS1.1) (34). A 
plaque-purified isolate of KOS (called KOSLarge) was sequenced by our own group using a stock 
obtained from Hendricks, Kinchington and colleagues (29, 57). Previous work by Iwasaki and 
colleagues (37) highlighted potential immune-evasion differences in the isolates of HSV-1 KOS 
held by different labs, but the genetic basis of these variants has not been investigated. Here we 
present the first analysis of overall genetic identity among the five publicly available genome 
sequences of KOS, and we extend this comparison to include newly sequenced genomes of the 
historically-dated strains KOS63 and KOS79. These additional strains have distinct levels of 
virulence in animal models, as previously characterized by Dix et al (22), with KOS79 showing 
significantly higher levels of neurovirulence and neuroinvasiveness than KOS63.  
 
One of the differences between KOS79 and KOS63 that may contribute to the higher virulence 
of KOS79 in vivo is its intact US9 protein. Previous authors have shown that US9 is involved in 
anterograde transport of viral capsids and glycoproteins to axonal termini in related 
alphaherpesviruses, such as pseudorabies virus (PRV) (58–60). However the role of US9 in 
anterograde transport of HSV-1 is less clear (61–64). KOS63 and its variants have a mutation 
present in the TATA-box promoter region of the membrane protein US9, as well as a substitution 
at position 58 in the US9 gene. This substitution introduces an early stop codon, and truncates 
the last 32 residues of the US9 protein (32, 41). This mutation removes the stop codon and 
elongates the neighboring open reading frame of US8A, a protein of undetermined function (32, 




































































future studies on how the differences in other herpesvirus proteins contribute to their observed 
differences in virulence phenotypes.  
 
KOS63 and KOS79 were reportedly isolated from the same volunteer on separate occasions (15, 
22, 43). The historical record does not allow us to confirm these isolations or to collect a fresh 
isolate from the same individual, but the frequent usage of KOS63-like variants in labs around 
the world makes it imperative to clarify their history as much as possible. We present here a 
rapid PCR and restriction digest test to allow labs to easily distinguish between KOS79 and the 
classic KOS63-like strains. In past studies, authors did not distinguish whether KOS63 and 
KOS79 were passage variants—i.e. high- and low-passage variants from a common parental 
stock—or were unrelated isolates (40, 39). Here we showed that KOS79 is genetically distinct 
from KOS63-like strains, with sufficient divergence that one could posit independent geographic 
acquisitions of HSV-1 infection (43). These data remove the possibility that KOS63 represents a 
passage variant of KOS79, a hypothesis that arose from examples of attenuation by serial 
passage for related herpesviruses (65–67). If they arose in the same source, the historical dating 
of strains KOS63 and KOS79 (from 1963 and 1979 respectively; (22)) suggests that these viruses 
reactivated independently of one another and at different times. It is impossible to determine now 
whether these historical isolates also arose from different body sites, which emphasizes the 
importance of recording full clinical details for new isolates. In future studies of extant cases, it 
will be important to determine how viral reactivation and shedding occur in dual- or multiply-






































































Virus culture and DNA isolation 
Stocks of HSV-1 KOS63 and KOS79 were obtained from R. Dix and expanded in adherent 
MRC-5 (ATCC®, CCL-171) human fetal lung fibroblast cells. MRC-5 cultures grown in Eagle’s 
Minimum Essential Media (EMEM; Sigma-Aldrich) were infected at an MOI of 0.01 and 
harvested when cultures displayed significant cytopathic-effect (CPE). These master stocks were 
titered on Vero cells (ATCC®, CCL-81) for easier plaque visualization. For DNA preparation, 
MRC-5 cultures were infected at an MOI of 5 and viral genomic DNA (gDNA) was isolated via 
a nucleocapsid preparation assay previously described (68). Similarly prepared gDNA from 
KOSLarge (29) and from plaque-purified HSV-1 strain 17 were used in the RFLP and PCR studies  
below. 
 
Next generation sequencing 
Viral gDNA was sheared and prepared for sequencing on an Illumina MiSeq. Viral nucleocapsid 
DNA was sheared using a Covaris M220 sonicator/disruptor, with the following parameters: 60 
seconds duration, peak power 50, 10% duty cycle, at 4°C. The Illumina TruSeq DNA sample 
prep kit was used to prepare barcoded sequencing libraries, according to the manufacturer’s low-
throughput protocol. Libraries were quantified and assessed by Qubit (Invitrogen, CA), 
Bioanalyzer (Agilent), and qPCR for library adaptors (KAPA Biosystems). Paired-end 
sequencing (2 x 300 bp length) was carried out on our lab’s Illumina MiSeq instrument, 
according to manufacturer’s recommendations, with 17 pM input. All sequence data has been 




































































alignments are also openly available from the Lancaster University data archive at 
http://dx.doi.org/10.17635/lancaster/researchdata/29. 
 
Consensus viral genomes were assembled using a recently described viral genome assembly 
(VirGA) workflow (29). Briefly, this workflow performs a number of quality control filters, 
including removal of contaminating host sequences, adaptors from library preparation, or image-
acquisition artifacts. It then carries out multiple iterations of de novo assembly using SSAKE, 
which are combined into longer blocks of sequence (contigs) using Celera and GapFiller. The 
Mugsy alignment package is used to match these contigs to a reference genome for HSV-1 
(strain 17, JN555585). The best matching contigs are stitched into a single consensus genome 
using a VirGA-specific script called mafnet. Finally, an array of quality-control measures are 
used to annotate, query, and improve the draft consensus genome. These include comparing the 
pileup of raw sequence reads to the initial draft genome, detecting polymorphisms within the 
sequence, identification of sequence features, gaps, and low coverage areas, and validation of 
selected areas by PCR and Sanger sequencing. Consensus genome sequences for KOS79 and 
KOS63 have been deposited in GenBank under accessions KT425109 and KT425110. 
 
Pairwise identity and genetic distance comparisons 
Trimmed genome sequences, lacking the terminal copies of the large repeats, were used for 
genetic distance comparisons to avoid giving undue weight to the repeats. In strains KOSDavido, 
KOSKnipe, and KOS1.1, the lengths of several reiterations (also known as variable number 
tandem repeats, or VNTRs) have been artificially set to match the reiteration copy number from 




































































accession of KOSDavido (JQ673480) to locate and remove these regions from all pairwise 
calculations of distance and percent identity. ClustalW2 (69) was used to construct pairwise 
global nucleotide alignments between whole genome sequences and pairwise global amino acid 
alignments between ORFs. These alignments were utilized by downstream custom Python scripts 
to calculate percent identity, protein differences, and genetic distance between samples. Further, 
an all-vs.-all alignment was used to generate a NeighborNet phylogenetic network in SplitsTree 
(44, 45, 70) with Uncorrected P distances in order to illustrate potential evolutionary 
relationships between strains. 
 
Global genetic distance and recombination analyses 
KOS79 was incorporated into the genome-wide alignment from Szpara et al. (42) using MAFFT 
with input parameters specified to freeze the prior alignment (71). Addition of KOS79 and 
KOS63 did not alter the published alignment of any of the other 26 HSV-1 genomes (42). The 
source alignment is found on the accompanying data website to Szpara et al. (42): 
http://szparalab.psu.edu/hsv-diversity/. Genetic distances were calculated in MEGA6 (72) using 
the Maximum Composite Likelihood measure and a dendrogram was produced using the 
Unweighted Paired Group Mean (Arithmetic) method (UPGMA) with 1000 bootstrap replicates 
(73, 74). Recombination was analyzed using SimPlot (75). 
 
RFLP analysis 
Nucleocapsid DNA was digested overnight at 37
o
C using the restriction enzymes BamHI, EcoRI, 
and HindIII (New England BioLabs), according to the company’s specifications. 250 ng of DNA 




































































Samples were visualized on a 1.0% agarose gel with ethidium bromide (Fisher Bio-Reagents) 
after overnight separation. Digital digests of the corresponding draft genomes were carried out 
using the software Geneious (version 7.1.7, created by Biomatters, available from 
http://www.geneious.com). These predicted patterns were compared against actual banding from 
above digestions, to assess draft genome matching to the observed RFLP banding patterns.  
 
Restriction digest of PCR amplicons 
Primers were designed flanking NcoI and NdeI restriction endonuclease cut sites in UL14 and 
UL25 respectively (Table 1). HSV 17, KOS79, KOSLg and KOS gDNA was boiled for five 
minutes and then snap-cooled on ice for five minutes. PCR was conducted in 50 μl reaction 
volumes using 3 μl of template DNA, 1 unit of PrimeStar GXL DNA polymerase (Clontech), 
200 mM deoxynucleoside triphosphate, 1 μM primers, and 1X buffer. PCR conditions in an 
Eppendorf Mastercycler Nexus gradient were as follows: 98
°
C for 2 minutes, followed by 35 
cycles of denaturation at 98°C for 10 seconds, 15 seconds of annealing at 55°C for UL25 or 
60°C for UL14, and primer extension at 68°C for 1 minute. Final extension was carried out at 
68°C for 2 minutes. PCR amplicons were then subjected to restriction digest using NcoI and 
NdeI (New England Biosciences). 20 μl of PCR mixture containing the amplicon of interest was 
mixed with 5 μl of enzyme-appropriate buffer, 24 μl of water, and 1 μl of restriction 
endonuclease. Samples were incubated at 37°C for 1 hour, then heat inactivated at either 65°C 
for NdeI or 80°C for NcoI. Digested samples were then purified using a QIAquick PCR 
purification kit (Qiagen). Standard agarose gel electrophoresis was used to separate and visualize 
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Table 1: KOS variants and strains used for genome sequence comparisons. 
Abbreviated 
name 
Parent strain Accession Source lab (reference) 
KOSDavido KOS JQ673480 Davido and colleagues (32) 
KOSLarge KOS KM222721 Szpara and colleagues (29) 
KOSKinchington KOS JQ780693 Kinchington and colleagues
1
 
KOSKnipe KOS KT899744.1 Knipe and colleagues (34) 
KOS1.1 KOS KT887225.1 Knipe and colleagues (34) 
KOS63 KOS TBD Dix (22), Szpara and colleagues
2
 
KOS79 KOS79 TBD Dix (22), Szpara and colleagues
2
 
17 17 JN555585 McGeoch, Davison, and colleagues (20, 21, 76) 
1
KOSKinchington is described only by GenBank record; 
2
KOS63 and KOS79 are presented for 
the first time here. 
 
 














KOS79 300 bp 7,761,149 6,079,163 150,782 99.9% KT425109 







































































Table 3: Pairwise comparisons of genome-wide DNA identity (upper right) and 


























Percent pair-wise DNA identity  






98.3% 98.4% 99.0% 98.3% 98.5% 98.9% 98.7% 
KOS79 57 
 
98.4% 98.1% 98.6% 98.4% 98.1% 98.1% 
KOS63 61 65 
 
99.2% 99.3% 99.2% 99.1% 99.1% 
KOSDavido 61 65 4 
 
99.0% 99.3% 99.6% 99.7% 
KOSLarge 63 65 7 10 
 
99.6% 99.1% 99.0% 
KOSKinchington 61 65 3 2 9 
 
99.3% 99.2% 
KOSKnipe 61 65 5 4 11 3  98.9% 
KOS1.1 61 65 2 5 8 4 6  






































































Figure 1: Genome sequence comparisons reveal that KOS63 is as different from 
KOS79 as from the HSV-1 reference strain 17. The genome sequences of multiple 
variants of KOS63 (green) were compared to those of KOS79 (blue) and the HSV-1 
reference strain 17 (red). For every possible pairwise combination of genomes, we 
calculated the genetic distance and the percent DNA identity (see Methods for details; see 
also Table 3). Points are color-coded to reflect the pairs in each comparison, with strain 
labels next to each point (see below for abbreviations). The x-axis reflects decreasing 
percent identity, while the y-axis reflects increasing genetic distance. In both cases, more 
disparate pairwise comparisons will plot further from the origin. Shaded circles provide a 
visual guide to the groups of pairwise comparisons. Green shading indicates pairwise 
combinations of KOS63-like strains, blue shading indicates combinations involving strain 
KOS79, and red shading indicates combinations involving strain 17. Yellow shading 
indicates the sole pairwise combination of strains 17 and KOS79. Trimmed genome 
sequences, lacking the terminal copies of the large repeats, were used for all comparisons 
to avoid giving undue weight to the repeats. Reiteration lengths in several published 
strains (32, 34) are artificially matched to strain 17, so these regions were removed from 
all comparisons as well (see Methods for details). Abbreviations are as follows: Da, 
KOSDavido from Davido and colleagues (32); Lg, KOSLarge from Szpara and colleagues 
(29); Ki, KOSKinchington from Kinchington and colleagues (33); Kn, KOSKnipe and 1.1, 




































































(22), with genome sequenced here; 79, KOS79 as described by Dix and colleagues (22), 
with genome sequenced here; 17, HSV-1 reference strain 17, as initially published by 
McGeoch and colleagues (20, 21), and revised by Davison and colleagues (76). All 
GenBank accessions are listed in Table 1. 
 
Figure 2: Genetic distance reveals that KOS63 and KOSDavido cluster separately 
from KOS79 in a global collection of HSV-1 strains.  
We extended a prior dendrogram analysis of 26 HSV-1 strains of global distribution (42) to 
include strains KOS63 and KOS79. KOS63 and the originally-included KOSDavido strain both 
cluster with HSV-1 strains of Asian origin, while KOS79 groups with HSV-1 strains of 
European and North American origin. Dendrogram was calculated with UPGMA in MEGA 
(1,000 bootstrap replicates). Branch confidence values are indicated on the tree. Scale bar 
indicates the number of nucleotide substitutions per kilobase. 
 
Figure 3: Restriction digest patterns of HSV-1 UL14 and UL25 amplified regions.  
Schematic representation of UL14 (A) and UL25 (C) amplicons including predicted size and 
location of strain-specific NcoI (A) or NdeI (C) sites within each PCR amplicon. The sequence 
surrounding the distinctive NcoI cut site in KOS79 (A) and NdeI cut site in KOS63 (C) are 
highlighted in yellow, with other HSV-1 strains shown for comparison. Electrophoretic analyses 
of UL14 (B) and UL25 (D) amplicons with and without enzyme addition are shown for HSV-1 
strains 17, KOSLg, KOS79, and KOS63. Bands at 0.5kb and 1kb are marked on the 100 bp ladder 





































































Figure 4. RFLP analysis of HSV-1 KOS variants.  
Diagram of the HSV-1 genome (top) and predicted HindIII restriction sites (bottom). The  
location (A) and sizes (B) of the historical lettering systems for HindIII fragments (49–51) 
predicted for these genomes are also illustrated. Fusion of fragment O and I, due to loss of a 
HindIII site in gM (UL10), has been previously noted in a number of HSV-1 strains. This loss 
occurs in strain KOS79, both in the genome sequence (B) and in RFLP analysis (C) after HindIII 
digestion of viral nucleocapsid DNA. Abbreviations in the genome diagram are as follows: 







































































Figure 1: Genome sequence comparisons reveal that KOS63 is as different from 





































































Figure 2: Genetic distance reveals that KOS63 and KOSDavido cluster separately 































































































































































































































































































Supplementary Figures & Legends 
Supplementary Figure 1: SplitsTree analysis of KOS79 and KOS63-like variants. 
 
Supplementary Figure 1: SplitsTree analysis of KOS79 and KOS63-like variants. 
SplitsTree analysis (44, 45, 70) reveals the close relationship among the KOS63-like variants, as 
compared to either KOS79 or the HSV-1 reference strain 17. Inset (green box) provides an 
expanded view and labels for the compact section of the network containing KOS63-like strains. 
Trimmed genome sequences lacking the terminal copies of the large repeats that flank each 
unique region were excluded, so that these genome regions did not doubly influence the genetic 
relatedness. Likewise, reiterations set to match those of strain 17 were excluded, so that these did 
not unduly influence the network (see Methods for details). Genome accession numbers and 






































































Supplementary Figure 2: Simplot and BootScan comparison of KOS79 with 





































































Supplementary Figure 2: Simplot and BootScan comparison of KOS79 with 
consensus of the European/North American and Africa-1 clusters. 
SimPlot analysis (A) of KOS79, in comparison to KOS63, a consensus of the European/North 
American cluster (strains HF10, 17, McKrae, F, and H129), and a consensus of the Africa-1 
cluster (strains E08, E12, E13, E14, and E19) from our prior study (Figure 2) (42). KOS79 is 
most closely related to the European/North American consensus strain over most of its length, 
except for a few short regions where it is most similar to the Africa-1 consensus (e.g. between 
kilobases 45-50 and 97-102) or where no predominant background can be identified (e.g. 
between kilobases 60-65 and 80-85). These regions may represent recombination events, 
although whether recent or ancient cannot be known. The corresponding BootScan plot (B) 
shows chi-shaped crossover signals supportive of recombination with an African strain at ~97-
102 kb, although two other areas of African similarity have less well formed signs of crossover. 
Potential crossover events with KOS63 occur at 60-60 kb and 80-85 kb (B), although the 





































































Supplementary Tables  
Supplementary Table 1: Proteins varying between each pairwise combination of 
KOS63-like strains.  
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Supplementary Table 2: Primers for PCR Validation 
Primer Name Target Sequence 
KOS_UL14_F1 UL14 5'-GGGGAACACTATCTGTCGTTGTTGCAGC-3' 
KOS_UL14_R1 UL14 5'-GATCGTCTTGCGGACCAGGAGGAGCAA-3' 
KOS_UL14_F2_Seq UL14 5’-GCGTGAGGGTAAGGATGTG-3’ 
KOS_UL14_F2.1_Seq UL14 5’-GCGTGAGGGTGAGGATGTG-3’ 
KOS_UL14_R2_Seq UL14 5’-CTGGTCATGTGGCAGCTAA-3’ 
KOS_UL25_F1 UL25 5'-GTCGATATCGAGCGCCGGTTAC-3' 
KOS_UL25_R1 UL25 5'-GGTACAGCAGGTAGAGACACAACAC-3' 
KOS_UL25_F2_Seq UL25 5’-CGGAACGTGCACGAGAT-3’ 
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A UL14 amplicon 
NcoI cut-site
761 bp
559 bp 202 bp
HSV-17: G G C C C C G T G G G G G T 
KOS63: G G C C C C G T G T G G G T  


















HSV-17: G C T A C A C A T G G T G T  
KOS63: G C T A C A T A T G G T G T  
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Supplementary Figure 1: SplitsTree analysis of KOS79 and KOS63-like variants. 
 
Supplementary Figure 1: SplitsTree analysis of KOS79 and KOS63-like variants. 
SplitsTree analysis (44, 45, 70) reveals the close relationship among the KOS63-like variants, as 
compared to either KOS79 or the HSV-1 reference strain 17. Inset (green box) provides an 
expanded view and labels for the compact section of the network containing KOS63-like strains. 
Trimmed genome sequences lacking the terminal copies of the large repeats that flank each 
unique region were excluded, so that these genome regions did not doubly influence the genetic 
relatedness. Likewise, reiterations set to match those of strain 17 were excluded, so that these did 
not unduly influence the network (see Methods for details). Genome accession numbers and 
sources are listed in Table 1. 
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Supplementary Figure 2: Simplot and BootScan comparison of KOS79 with 
consensus of the European/North American and Africa-1 clusters. 
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Supplementary Figure 2: Simplot and BootScan comparison of KOS79 with 
consensus of the European/North American and Africa-1 clusters. 
SimPlot analysis (A) of KOS79, in comparison to KOS63, a consensus of the European/North 
American cluster (strains HF10, 17, McKrae, F, and H129), and a consensus of the Africa-1 
cluster (strains E08, E12, E13, E14, and E19) from our prior study (Figure 2) (42). KOS79 is 
most closely related to the European/North American consensus strain over most of its length, 
except for a few short regions where it is most similar to the Africa-1 consensus (e.g. between 
kilobases 45-50 and 97-102) or where no predominant background can be identified (e.g. 
between kilobases 60-65 and 80-85). These regions may represent recombination events, 
although whether recent or ancient cannot be known. The corresponding BootScan plot (B) 
shows chi-shaped crossover signals supportive of recombination with an African strain at ~97-
102 kb, although two other areas of African similarity have less well formed signs of crossover. 
Potential crossover events with KOS63 occur at 60-60 kb and 80-85 kb (B), although the 
SimPlot signals in these areas are not strong (A). 
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Supplementary Table 1: Proteins varying between each pairwise combination of 
KOS63-like strains.  
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Supplementary Table 2: Primers for PCR Validation 
Primer Name Target Sequence 
KOS_UL14_F1 UL14 5'-GGGGAACACTATCTGTCGTTGTTGCAGC-3' 
KOS_UL14_R1 UL14 5'-GATCGTCTTGCGGACCAGGAGGAGCAA-3' 
KOS_UL14_F2_Seq UL14 5’-GCGTGAGGGTAAGGATGTG-3’ 
KOS_UL14_F2.1_Seq UL14 5’-GCGTGAGGGTGAGGATGTG-3’ 
KOS_UL14_R2_Seq UL14 5’-CTGGTCATGTGGCAGCTAA-3’ 
KOS_UL25_F1 UL25 5'-GTCGATATCGAGCGCCGGTTAC-3' 
KOS_UL25_R1 UL25 5'-GGTACAGCAGGTAGAGACACAACAC-3' 
KOS_UL25_F2_Seq UL25 5’-CGGAACGTGCACGAGAT-3’ 
KOS_UL25_R2_Seq UL25 5’-CGTCATGAAGGTCTTGGACA-3’ 
 
 
